CN116195739A - 一种用于肠道清洁的膳食 - Google Patents
一种用于肠道清洁的膳食 Download PDFInfo
- Publication number
- CN116195739A CN116195739A CN202310422168.0A CN202310422168A CN116195739A CN 116195739 A CN116195739 A CN 116195739A CN 202310422168 A CN202310422168 A CN 202310422168A CN 116195739 A CN116195739 A CN 116195739A
- Authority
- CN
- China
- Prior art keywords
- diet
- vitamin
- whey protein
- protein
- intestinal tract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000005911 diet Nutrition 0.000 title claims abstract description 41
- 230000037213 diet Effects 0.000 title claims abstract description 36
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 32
- 238000004140 cleaning Methods 0.000 title claims abstract description 10
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 64
- 235000021119 whey protein Nutrition 0.000 claims abstract description 60
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 58
- 235000018102 proteins Nutrition 0.000 claims abstract description 24
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 24
- 229920001353 Dextrin Polymers 0.000 claims abstract description 19
- 239000004375 Dextrin Substances 0.000 claims abstract description 19
- 235000019425 dextrin Nutrition 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 14
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 11
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 11
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 11
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 11
- 241000251468 Actinopterygii Species 0.000 claims abstract description 8
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 8
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 8
- 229920002752 Konjac Polymers 0.000 claims abstract description 7
- 235000013312 flour Nutrition 0.000 claims abstract description 7
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 6
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 29
- 235000016709 nutrition Nutrition 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 102000011632 Caseins Human genes 0.000 claims description 6
- 108010076119 Caseins Proteins 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- 239000005862 Whey Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 239000001116 FEMA 4028 Substances 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 235000004347 Perilla Nutrition 0.000 claims description 4
- 244000124853 Perilla frutescens Species 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 4
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 4
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 4
- 229960004853 betadex Drugs 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 235000020197 coconut milk Nutrition 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- 239000011706 ferric diphosphate Substances 0.000 claims description 4
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 4
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 4
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000000395 magnesium oxide Substances 0.000 claims description 4
- 229960000869 magnesium oxide Drugs 0.000 claims description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 229940067631 phospholipid Drugs 0.000 claims description 4
- 150000003904 phospholipids Chemical class 0.000 claims description 4
- 229960000342 retinol acetate Drugs 0.000 claims description 4
- 235000019173 retinyl acetate Nutrition 0.000 claims description 4
- 239000011770 retinyl acetate Substances 0.000 claims description 4
- 229940080237 sodium caseinate Drugs 0.000 claims description 4
- 239000001509 sodium citrate Substances 0.000 claims description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 4
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960000306 zinc gluconate Drugs 0.000 claims description 4
- 239000011670 zinc gluconate Substances 0.000 claims description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims description 4
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 229940091250 magnesium supplement Drugs 0.000 claims description 3
- 239000011572 manganese Substances 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 239000011772 phylloquinone Substances 0.000 claims description 3
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 229960001518 levocarnitine Drugs 0.000 claims description 2
- 229960002737 fructose Drugs 0.000 claims 1
- 235000020888 liquid diet Nutrition 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 19
- 235000013305 food Nutrition 0.000 abstract description 17
- 238000010521 absorption reaction Methods 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 9
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 230000029087 digestion Effects 0.000 abstract description 6
- 229920002472 Starch Polymers 0.000 abstract description 5
- 235000019698 starch Nutrition 0.000 abstract description 5
- 239000008107 starch Substances 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000013872 defecation Effects 0.000 abstract description 2
- 235000020879 medical diet Nutrition 0.000 abstract description 2
- 239000006041 probiotic Substances 0.000 abstract description 2
- 235000018291 probiotics Nutrition 0.000 abstract description 2
- 239000000306 component Substances 0.000 abstract 1
- 235000021245 dietary protein Nutrition 0.000 abstract 1
- 235000012041 food component Nutrition 0.000 abstract 1
- 239000005428 food component Substances 0.000 abstract 1
- 230000036186 satiety Effects 0.000 abstract 1
- 235000019627 satiety Nutrition 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 description 26
- 238000002052 colonoscopy Methods 0.000 description 17
- 206010009944 Colon cancer Diseases 0.000 description 13
- 238000011160 research Methods 0.000 description 13
- 239000006260 foam Substances 0.000 description 12
- 235000012054 meals Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000035764 nutrition Effects 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 206010067484 Adverse reaction Diseases 0.000 description 7
- 230000006838 adverse reaction Effects 0.000 description 7
- 208000026935 allergic disease Diseases 0.000 description 7
- 230000007815 allergy Effects 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 230000000172 allergic effect Effects 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 230000000378 dietary effect Effects 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 102000014171 Milk Proteins Human genes 0.000 description 4
- 108010011756 Milk Proteins Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000003642 hunger Nutrition 0.000 description 4
- 235000010485 konjac Nutrition 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- 230000003749 cleanliness Effects 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000021004 dietary regimen Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000003200 Adenoma Diseases 0.000 description 2
- 206010001233 Adenoma benign Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011469 Crying Diseases 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 108010060630 Lactoglobulins Proteins 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 238000012356 Product development Methods 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000004218 vascular function Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 206010036772 Proctalgia Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 201000002758 colorectal adenoma Diseases 0.000 description 1
- 208000030251 communication disease Diseases 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 201000005298 gastrointestinal allergy Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000022131 polyp of large intestine Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000013538 segmental resection Methods 0.000 description 1
- 230000006128 skin development Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种用于肠道清洁的膳食,属于医学膳食领域。本申请的膳食以抗性糊精、麦芽糊精、水解乳清蛋白粉、海洋鱼低聚肽、魔芋粉为主要成分。食物中的可溶性膳食纤维具有较高的膨胀性可以增大内容物的体积,易使人产生饱腹感,同时较高的持水力有利于排便。水解乳清蛋白以短肽形式存在,更容易被人体消化吸收,有着较高的吸收率。另外,水解乳清蛋白具有较强的免疫作用与抗菌作用,对一些益生菌具有明显促进作用。不同食品成分消化需要时间各异,淀粉类为2~3h,蛋白质类为4h,而脂肪类为6~8h。本食品蛋白质提供能量24%,脂肪占3%,碳水化合物占25%。脂肪占比较低,利于食物在短期内消化吸收。袋装包装,轻巧便利,40℃温水即溶可食用。
Description
技术领域
本发明涉及医学膳食领域,具体涉及一种用于肠道清洁的膳食。
背景技术
结直肠癌是全球第三常见的恶性肿瘤,也是致死率排名第二的癌症。随着中低收入国家饮食结构不断西化,结直肠癌的负担正在向这些国家转移。年轻人群(50岁以下)结直肠癌发病率上升是另一个新趋势。结直肠癌近年来已成为严重危害我国居民健康的重大公众问题,其发病率逐年攀升。一项关于中国结直肠癌发病率和死亡率趋势和预测的研究指出,2025年,中国男性、女性结直肠癌患者将分别达到41.09万、23.14万。国内外大量研究和临床实践表明,结肠镜检查在全球各地被广泛作为结直肠癌筛查的首选方案,也是我国筛查结直肠癌最常用的方法。结肠镜检查用于结直肠癌筛查可降低结直肠癌的发病率和死亡率,改善该疾病的预后。充分的肠道准备对于成功开展结肠镜检查至关重要。研究表明,高达30%的结肠镜检查患者肠道清洁不佳。这可能降低息肉和腺瘤检出率,增加筛查失败风险和重复手术的可能性。饮食限制可减少肠道中的食物残渣,提高肠道的清洁度和肠镜下的视野清晰度,进而改善肠道准备质量。为保证肠道准备质量,临床医护人员通常建议患者提前2~3天进行适当的饮食管理,尤其是长期便秘患者。由于部分患者自我管理水平较低,患者对提前2-3天饮食限制的依从性往往与医务人员的期望背道而驰。根据2019年发布的《中国消化内镜诊疗相关肠道准备指南》,肠道准备饮食限制不宜超过24小时,可采用术前低渣饮食、术前一天清流质饮食、预包装低渣饮食等方式。
临床肠道饮食限制暂无统一的时间和饮食种类标准,各家医疗中心的饮食限制方式存在很大差异。在实际应用过程中,饮食种类和总量难以控制,因饮食不当而导致的肠道准备失败屡见不鲜。
发明内容
针对现有技术的不足,本发明提出了一种用于肠道清洁的膳食。
本发明的目的可以通过以下技术方案实现:
一种用于肠道清洁的膳食,包括:
抗性糊精、麦芽糊精、乳清蛋白、海洋鱼低聚肽与魔芋粉。
可选地,还包括食用香精。
可选地,还包括木糖醇、椰浆粉、低聚果糖、低聚半乳糖、磷酸氢二钾、磷酸三钙、紫苏子油微囊粉、柠檬酸钠、结晶果糖、左旋肉碱、复配营养强化剂、酪蛋白酸钠、氧化镁、β-环状糊精、磷脂、黄原胶、牛磺酸、葡萄糖酸锌、焦磷酸铁与醋酸视黄酯。
可选地,所述乳清蛋白为水解乳清或蛋白肽或氨基酸。
可选地,所述膳食中包含以下质量比例的营养成分:
碳水化合物46.8175%、蛋白质24%、脂肪20%、膳食纤维3.5%、维生素A0.30×10-3%、维生素D 5.5×10-6%、维生素E 5.5×10-3%、维生素K1 32×10-6%、维生素B10.525×10-3%、维生素B2 0.525×10-3%、维生素B6 0.525×10-3%、维生素B12 0.90×10-6%、烟酰胺5.75×10-3%、叶酸0.15×10-3%、泛酸1.838×10-3%、维生素C 42.75×10-3%、生物素13.11×10-6%、钠0.5625%、钾0.75%、铜0.325×10-3%、镁0.125%、铁6×10-3%、锌5×10-3%、锰1.25×10-3%、钙0.325%、磷0.28%、碘0.05×10-3%、氯0.4%、硒25×10-6%、胆碱0.155%、牛磺酸0.07%、左旋肉碱0.14%。
上述的膳食在肠道手术前饮食管理中的应用。
本发明的有益效果:
1.提高结肠镜检查患者的饮食依从性。
2.提高结肠镜检查患者的肠道准备质量。
3.降低结肠镜患者肠道准确期间低血糖的发生率。
具体实施方式
下面将本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
本发明的一些示例中,公开了一种膳食,选取麦芽糊精,抗性糊精,海洋鱼低聚肽,水解乳清蛋白粉,木糖醇,魔芋粉,椰浆粉,低聚果糖,低聚半乳糖,磷酸氢二钾,磷酸三钙,紫苏子油微囊粉,柠檬酸钠,结晶果糖,左旋肉碱,复配营养强化剂,酪蛋白酸钠,氧化镁,β-环状糊精,磷脂,黄原胶,牛磺酸,葡萄糖酸锌,焦磷酸铁,醋酸视黄酯,食用香精等材料成分作为原料,其主要成分为抗性糊精、麦芽糊精、水解乳清蛋白粉、海洋鱼低聚肽、魔芋粉。
抗性糊精是一种功能性膳食纤维,在现代工业各个领域有着广泛的应用。作为七大营养素之一的膳食纤维在清除食物中有害成分和致癌物质等方面起着重要作用,对于肠道类疾病的预防和治疗以及健康减脂具有重要意义。世界卫生组织建议成人每天平均摄入37g膳食纤维,在追求健康饮食的今天,膳食纤维生产稳步提高,应用日益广泛。抗性糊精作为膳食纤维的一部分,在含有α-1,2-糖苷键、β-1,6-糖苷键和葡聚糖等基础上,还含有许多特殊结构,赋予了抗性糊精特殊功能。由于抗性糊精淀粉原料、生产方法等的不同会得到不同纯度和性质的抗性糊精,优化抗性糊精工艺及不同原料生产抗性糊精是目前的研究热点。抗性糊精具有微甜、耐酸、耐压、耐热、耐冷冻、低褐变、耐储藏等性质,添加到食品中不会大幅改变食品的品质。膳食纤维持水能力承受范围约为本身质量的1.5~25倍。较高的膨胀性可以增大内容物的体积,易使人们产生饱腹感,同时较高的持水力有利于排便。近年来,研究者通过动物实验、临床试验等证明了抗性糊精具有减重、降血脂、降血糖、调节肠道菌群等功能抗性糊精在临床研究中被证明可以改善2型糖尿病,减轻HFD喂养小鼠的肥胖和脂肪组织炎症。基于抗性糊精能抑制人体小肠对各种糖类的消化吸收,能明显抑制血糖和胰岛素上升。
麦芽糊精是以淀粉或淀粉质为原料,经酶法低度水解、精制、喷雾干燥制成的不含游离淀粉的淀粉衍生物。麦芽糊精流动性好,无异味,溶解性能好,耐热性强,吸湿性低,不结团,即使在浓度高的状态下使用也不会掩盖其他原料的风味和香味,具有很好的载体作用,常用在果汁类产品的干燥过程中起到助干剂的作用,从而防止果汁粉产品结块,增加产品的溶解性,改善产品组织结构。随着食品工业的加速发展,配料市场迫切需要具有功能特性和营养特性的蛋白质作为食品原料。因此一方面要大力开发具有优良特性的蛋白质的资源,另一方面需要对现有的蛋白质进行改造,以满足其在食品中的特殊要求,这就是蛋白质的改性。麦芽糊精主要通过与蛋白质发生美拉德反应,从而改善蛋白的功能特性。
乳清蛋白在适当温度下及pH下进行酶促反应所得产物即为水解乳清蛋白,其一般以一种蛋白预消化的形式存在,相比于以整个蛋白形式存在的乳清蛋白分子量更小、更容易消化吸收、潜在致敏性更弱。近年来,人们营养健康意识逐渐的提升,水解乳清蛋白的需求量也越来越大。随着新工艺的不断发展,水解乳清蛋白不仅具有较高的利用价值,而且在产品开发研究、食品加工中也发挥着重要的作用。其对于保健食品、过敏性食品、餐包类食品等产品的开发提供了较好的基础原料。因此,近几年,水解乳清蛋已成为国内外各学者的研究热点,在食品加工、产品开发中发挥重要的作用。水解乳清蛋白主要以短肽形式存在,是乳清蛋白的水解物。根据其水解程度可分为适度水解乳清蛋白与深度水解乳清蛋白。目前,国内外制备水解乳清蛋白的方法颇多,但酶解法是最为常用方法之一,其成本低,安全性高,生产条件温和易控制,可进行大规模生产。相关研究调查表明,将水解乳清蛋白酶作用于乳清蛋白中,使其内具有生物活性的氨基酸序列进行释放,发挥出功能效应。水解乳清蛋白相比于乳清蛋白具有以下等特点:(1)有利于肠道吸收水解乳清蛋白多以短肽形式存在,渗透压较低,经小肠肽酶水解后可直接被吸收,提高肠内营养的耐受性,对于肠胃功能较差的人群,可优先食用。(2)抗氧化作用水解乳清蛋白可以消除自由基和过氧化物。Peng和彭新艳研究结果表明:水解乳清蛋白的分子量大小可对其抗氧化能力产生一定影响;水解乳清蛋白相比乳清蛋白具有改善机体代谢絮乱以及延缓衰老等特点。(3)改善骨密度、促进钙吸收潘道东等相关研究证明,水解乳清蛋白有类似于酪蛋白磷酸肽功能的多肽成分,可更好的促进钙吸收,促进骨钙沉淀,增加骨骼密度。同时说明了,适量的水解乳清蛋白,即可更好的促进钙的吸收。(4)预防肠道过敏婴幼儿牛乳过敏的致敏因子主要由β-乳球蛋白与a-乳清蛋白所导致,其约占乳清蛋白的70%-80%。通常利用乳清蛋白酶解改性得到的水解乳清蛋白,其对人体的免疫系统具有促进作用,可有效破坏β-乳球蛋白、a-乳清蛋白的致敏结构,从而减少儿童过敏性疾病的发生。(5)对血压和血管功能的有益作用水解乳清蛋白具有抗血压的作用,Ballard等研究发现,具有调节血压与血管功能的作用。
牛乳蛋白质与母乳蛋白质相比具有一定的不同,以牛乳蛋白为原料的儿童配方粉容易引起其消化不良或过敏现象。主要表现为大声哭闹、腹泻呕吐、哮喘、胃肠道不适等。牛乳中酪蛋白占比较多,其中a-酪蛋白的含量较高,这种蛋白较易导致儿童肠胃不适、过敏等症状。母乳中主要以乳清蛋白为主,而牛乳中的乳清蛋白以P-乳球蛋白为主。研究表明,这种蛋白是儿童过敏的主要来源。因此,常利用蛋白酶进行蛋白水解,得到的水解牛乳蛋白添加到儿童配方中可有效改善其过敏现象。P-乳球蛋白主要存在于牛乳中的乳清蛋白中,其乳清蛋白是儿童配方中主要蛋白的来源,因此用水解乳清蛋白部分或完全替代儿童配方乳粉中的乳清蛋白不仅有利于儿童的消化吸收,同时还可以降低儿童发生过敏反应的机率。水解乳清蛋白具有预防过敏及低抗原性外,最为主要的是水解乳清蛋白以短肽形式存在,更容易被人体消化吸收,有着较高的吸收率。另外,水解乳清蛋白具有较强的免疫作用与抗菌作用,其本身也是肠道生物的营养源,对于一些益生菌具有明显的促进作用。
水解乳清蛋白在食品中的应用研究主要集中在国外。Von Berg等对部分水解乳清蛋白、完全水解乳清蛋白、不含有水解乳清蛋白的同类产品进行比较研究,研究结果表明,部分水解乳清蛋白与完全水解乳清蛋白产品发生变态反应性皮肤的概率远远低于不含有水解乳清蛋白配方产品。Halken等研究比较了适度水解与深度水解乳清蛋白对婴幼儿过敏症状的影响,结果显示,深度水解乳清蛋白对婴幼儿产生过敏症状的几率最低,不含有水解乳清蛋白配方产品对婴幼儿产生过敏较为严重。另外,相关研究显示,儿童食用水解乳清蛋白类产品相比普通蛋白类产品,较易吸收,不易发生腹泻等现象。
水解乳清蛋白主要以短肽及水解蛋白的形式存在,具有低渗透压、低抗原性、肠道耐受性等特点,较易被人体吸收,可促进肠道微生物对营养物质的利用、有利于氨基酸及微量元素吸收等优点,提高了产品整体的消化率,调整负氮平衡,避免患者过敏、腹泻及肠胃不舒服等不良反应。在此基础上,水解乳清蛋白作为蛋白质来源已被临床应用于各类短肽型肠内营养剂。国内外研究表明,短肽型肠内营养剂能够明显改善病重患者的营养状况,提高患者的整体蛋白水平,对改善人体免疫力、预防肠道菌群移位具有积极性作用。短肽型肠内营养制剂在免疫改善、临床效用、肠道耐受等方面明显好于整蛋白型肠内营养制剂。咎学琴等研究发现短肽营养剂在食道切除治疗中具有较好的效果,可以改善患者的营养状态。周华健与蒋晓松对结肠癌患者在术前3d用短肽营养剂代替传统的流质饮食,结果表明,其能够保证肠道的清洁度以使患者的营养状态得到改善,为手术创造较好的环境。与此同时,可减少患者在术后的并发症等现象。
海洋鱼低聚肽是介于蛋白质与氨基酸之间的高分子化合物,除具有蛋白分子特性外,还具有一些生理性功能,如抗疲劳、抗氧化、免疫调节、降血压、降血脂等功效。
魔芋粉可增加肠道的功能,并能抑制小肠对水分的吸收及肠壁水分被吸收进肠道,从而软化大便,起到通便作用,并加速有毒物质的排泄,减少癌原物质与大肠粘膜的接触时间,故也能预防和治疗结肠癌。
本发明的一些具体的实施例中,公开了一种预包装膳食,选取麦芽糊精,抗性糊精,海洋鱼低聚肽,水解乳清蛋白粉,木糖醇,魔芋粉,椰浆粉,低聚果糖,低聚半乳糖,磷酸氢二钾,磷酸三钙,紫苏子油微囊粉,柠檬酸钠,结晶果糖,左旋肉碱,复配营养强化剂,酪蛋白酸钠,氧化镁,β-环状糊精,磷脂,黄原胶,牛磺酸,葡萄糖酸锌,焦磷酸铁,醋酸视黄酯,食用香精等材料成分作为原料。
本实施例中的膳食包含以下质量比例的营养成分:
碳水化合物46.8175%、蛋白质24%、脂肪20%、膳食纤维3.5%、维生素A0.30×10-3%、维生素D 5.5×10-6%、维生素E 5.5×10-3%、维生素K1 32×10-6%、维生素B10.525×10-3%、维生素B2 0.525×10-3%、维生素B6 0.525×10-3%、维生素B12 0.90×10-6%、烟酰胺5.75×10-3%、叶酸0.15×10-3%、泛酸1.838×10-3%、维生素C 42.75×10-3%、生物素13.11×10-6%、钠0.5625%、钾0.75%、铜0.325×10-3%、镁0.125%、铁6×10-3%、锌5×10-3%、锰1.25×10-3%、钙0.325%、磷0.28%、碘0.05×10-3%、氯0.4%、硒25×10-6%、胆碱0.155%、牛磺酸0.07%、左旋肉碱0.14%。
本实施例的预包装食品蛋白质提供能量35%,脂肪占27%,碳水化合物占比18%,脂肪占比较低,利于食物在短期内消化吸收。袋装包装,轻巧便利,40℃温水即溶可食用。
在本发明的一些示例中,确定结肠镜检查,着手进行肠道准备时,提供6袋(每袋40g)上述实施例中的膳食,检查前24小时患者根据自己的饮食需求食用本食品,若有饥饿感,可增食用量,控制在10袋以内。准备约40℃的温水和一次性使用玻璃容器进行冲泡,充分搅拌后食用。
在本发明的一些具体的实施例中,公开了对于上述实施例的膳食效果的验证试验。
试验的样本包括若干结肠镜检查住院患者,年龄≥18岁,且≤75岁;患者本人签署知情同意书。
排除标准:①便秘患者;②结直肠恶性肿瘤患者;③结直肠部分切除患者;④心、肝、肾功等重要脏器功能障碍者;⑤患有精神疾病、意识障碍及沟通障碍等;⑥孕产妇;⑦对肠道准备过程中涉及用药和食物任何可疑过敏者;⑧糖尿病患者⑨近期参与其他研究者。
剔除标准:①违反干预方案操作者,或未按照研究方法规定治疗者;②发生严重不良反应事件,出现并发症不宜继续接受治疗者;③自行退出或未完成整个疗程而影响疗效判断者。
通过计算机产生随机序列把预计纳入的样本含量输入统计软件包SPSS,确定随机种子数、顺序号、得出随机号和分组结果,制作随机卡片,封入不透光的信封中。临床实施时按合格病例纳入试验的先后顺序对应信封上的序号顺序拆开信封,依照随机卡片上的提示进行分组,分别为对照组和干预组。
对照组:三餐由患者常规自行准备低渣饮食,包括面条,米粥,藕粉,鸡蛋羹等。检查前一日三餐自备低渣饮食(面条、米粥等),19:00服用聚乙二醇1袋+1L温水(每15分钟服用250ml,一个小时内服完),检查当日03:00服用聚乙二醇2袋+2L温水(每15分钟服用250ml,两个小时内服完),聚乙二醇喝完即服用西甲硅油30ml,后禁食禁水。服药期间来回走动,轻揉腹部,排便至大便呈清水样(无色或者黄色透明水样)。
干预组:预包装检查餐,由营养科提供标准化预包装检查餐共6440KJ,10袋(每袋净重40g,644KJ的热量)。该预包装检查餐主要成分包括麦芽糊精,抗性糊精,海洋鱼低聚肽,水解乳清蛋白粉等。检查前一日三餐食用食堂配送预包装检查餐,19:00服用聚乙二醇1袋+1L温水(每15分钟服用250ml,一个小时内服完),检查当日04:00服用聚乙二醇2袋+2L温水(每15分钟服用250ml,两个小时内服完),聚乙二醇喝完即服用西甲硅油30ml。禁食禁水,服用药物期间来回走动,轻揉腹部,排便至大便呈清水样(无色或者黄色透明水样)。
对于上述的试验对象,进行肠道情况的评估。
其中,主要结局指标可以是波士顿肠道准备评分。
(1)波士顿肠道准备(boston bowel preparation scale,BBPS)
波士顿肠道准备评分量表:每部分肠道BBPS评分为0~3分,BBPS总分为0~9分,分数越高代表肠道准备越充分,肠道准备合格的标准为每个肠段不低于2分,肠道准备不合格标准为总分低于6分或任意肠段低于2分。
(2)肠道准备依从性
肠道准备结束后由患者自己评判,全部依从为合格,一项不依从则判定为不依从。
次要评价指标
(1)饥饿VAS评分
以0~10cm的水平做标尺,量表的左端0代表没有这种感觉,右侧10代表有强烈的感觉。前一天晚上睡觉前指导患者在VAS线上做记号。根据患者在VAS线上做的标记记录症状得分。
(2)泡沫评分
根据泡沫对肠道粘膜可见度的影响,分为0分(全肠道无泡沫或少量泡沫,视野清楚,泡沫覆盖<5%),1分肠道内少量泡沫,不影响视野(泡沫覆盖5%-25%),2分肠道大量泡沫,水可冲尽,不影响镜下观察中等或明显存在的气泡(泡沫覆盖50%),3分结肠大量泡沫,流水无法冲尽(泡沫覆盖≥50%),每段均为0-3分,总分为0-9分,评分由结肠镜检查操作医生在操作过程中评价。
(3)患者再次以同种方式进行肠道准备的意愿完全能接受得1分;虽有不适,但能接受得2分;完全不能接受得3分。
(4)肠道准备期间不良反应发生率
由护士询问在肠道准备期间有无恶心、呕吐、腹胀、腹痛、饥饿感、头晕、肛门疼痛不良反应,并记录,每出现一次症状的患者例数占同期结肠镜检查总数的比例。即为症状人次/结肠镜检查人次。
(5)结肠镜检查后不良反应发生率
患者肠镜检查回室后24小时内护士询问不良反应发生腹痛、腹胀、恶心、呕吐症状,每出现一次症状的患者例数占同期结肠镜检查总数的比例。
(6)腺瘤检出率
指结肠镜检查中至少检出一枚结直肠腺瘤的患者占同期结肠镜检查总数的比例。
(7)息肉检出率
指结肠镜检查中至少发现一枚结直肠息肉的患者占同期结肠镜检查总数的比例。
(8)退镜操作时长
记录开始退镜至肛门的总时间,这些时间由辅助结肠镜检查的护士记录。
(9)清肠排泄次数
记录口服清肠药物开始至结肠镜检查前的清肠排泄次数。
前期试验结果见下表1、表2:
表1:两组患者一般资料
表2:两组患者干预前后资料
通过上述的实验结果表明,与对照组相比,通过本申请实施例的膳食进行膳食肠道准备的患者组,获得了更高的BBPS评分,以及更高的合格率。另外在一些次要评价标准中,通过本实施例的膳食进行膳食肠道准备的患者组具有更好的饥饿VAS评分以及泡沫评分,以及更低的肠道准备期间和结肠镜检查后的不良反应发生率,进而验证采用本实施例的膳食方案能够提高肠道的清洁度和肠镜下的视野清晰度,同时减少了患者的不适。
综上所述,本申请的膳食方案与现有的膳食方案想相比,能够显著提高饮食依从性以及肠道准备质量,并减少了患者在膳食准备期间的饥饿感以及肠道准备期间和结肠镜检查后的不适反应。
在本说明书的描述中,参考术语“一个实施例”、“示例”、“具体示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。
Claims (6)
1.一种用于肠道清洁的膳食,其特征在于,包括:
抗性糊精、麦芽糊精、乳清蛋白、海洋鱼低聚肽与魔芋粉。
2.根据权利要求1所述的用于肠道清洁的膳食,其特征在于,所述的膳食为可冲泡固体颗粒或者流食形式。
3.根据权利要求1所述的用于肠道清洁的膳食,其特征在于,还包括木糖醇、椰浆粉、低聚果糖、低聚半乳糖、磷酸氢二钾、磷酸三钙、紫苏子油微囊粉、柠檬酸钠、结晶果糖、左旋肉碱、酪蛋白酸钠、氧化镁、β-环状糊精、磷脂、黄原胶、牛磺酸、葡萄糖酸锌、焦磷酸铁与醋酸视黄酯。
4.根据权利要求1所述的用于肠道清洁的膳食,其特征在于,所述乳清蛋白为水解乳清或蛋白肽或氨基酸。
5.根据权利要求1所述的用于肠道清洁的膳食,其特征在于,所述膳食中包含以下质量比例的营养成分:
碳水化合物46.8175%、蛋白质24%、脂肪20%、膳食纤维3.5%、维生素A0.30×10-3%、维生素D 5.5×10-6%、维生素E 5.5×10-3%、维生素K1 32×10-6%、维生素B1 0.525×10-3%、维生素B2 0.525×10-3%、维生素B6 0.525×10-3%、维生素B12 0.90×10-6%、烟酰胺5.75×10-3%、叶酸0.15×10-3%、泛酸1.838×10-3%、维生素C 42.75×10-3%、生物素13.11×10-6%、钠0.5625%、钾0.75%、铜0.325×10-3%、镁0.125%、铁6×10-3%、锌5×10-3%、锰1.25×10-3%、钙0.325%、磷0.28%、碘0.05×10-3%、氯0.4%、硒25×10-6%、胆碱0.155%、牛磺酸0.07%、左旋肉碱0.14%。
6.权利要求1~5任一所述的膳食在肠道准备饮食中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310422168.0A CN116195739A (zh) | 2023-04-19 | 2023-04-19 | 一种用于肠道清洁的膳食 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310422168.0A CN116195739A (zh) | 2023-04-19 | 2023-04-19 | 一种用于肠道清洁的膳食 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116195739A true CN116195739A (zh) | 2023-06-02 |
Family
ID=86519457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310422168.0A Pending CN116195739A (zh) | 2023-04-19 | 2023-04-19 | 一种用于肠道清洁的膳食 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116195739A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007794A (zh) * | 2018-06-11 | 2018-12-18 | 河北健素临床营养有限公司 | 增加肠道耐受性的全营养食品 |
CN109043505A (zh) * | 2018-07-03 | 2018-12-21 | 麦孚营养科技(北京)有限公司 | 海洋鱼低聚肽低渣营养配方制品、其制备方法及其用途 |
CN113545479A (zh) * | 2021-07-22 | 2021-10-26 | 陕西巨子生物技术有限公司 | 一种配方食品及其应用 |
CN115067504A (zh) * | 2022-06-29 | 2022-09-20 | 医林营海(江苏)营养科技有限公司 | 用于肠道准备的特医食品及其制备方法 |
-
2023
- 2023-04-19 CN CN202310422168.0A patent/CN116195739A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109007794A (zh) * | 2018-06-11 | 2018-12-18 | 河北健素临床营养有限公司 | 增加肠道耐受性的全营养食品 |
CN109043505A (zh) * | 2018-07-03 | 2018-12-21 | 麦孚营养科技(北京)有限公司 | 海洋鱼低聚肽低渣营养配方制品、其制备方法及其用途 |
CN113545479A (zh) * | 2021-07-22 | 2021-10-26 | 陕西巨子生物技术有限公司 | 一种配方食品及其应用 |
CN115067504A (zh) * | 2022-06-29 | 2022-09-20 | 医林营海(江苏)营养科技有限公司 | 用于肠道准备的特医食品及其制备方法 |
Non-Patent Citations (2)
Title |
---|
叶乐驰;郑晨果;蒋芳;: "百普素联合恒康正清在术前肠道准备中的应用", 海峡药学, no. 11, 30 November 2010 (2010-11-30), pages 1 * |
常映明: "抗衰老漫谈 点燃生日蛋糕上的第120根蜡烛", 30 November 2017, 中国医药科技出版社, pages: 51 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rabbani et al. | Clinical studies in persistent diarrhea: dietary management with green banana or pectin in Bangladeshi children | |
D’Antiga et al. | Intestinal failure in children: the European view | |
Bruck et al. | Galactosemia in an infant with cataracts: clinical observations and carbohydrate studies | |
CN105795481A (zh) | 一种术前专用型营养补充剂 | |
CN111543605A (zh) | 一种四高或肥胖人群用综合营养粉 | |
CN108740620A (zh) | 一种西梅澄清饮料及其制备方法 | |
Chao et al. | Therapeutic effect of Novalac-IT in infants with constipation | |
CN115067504B (zh) | 用于肠道准备的特医食品及其制备方法 | |
Hill | Oral nutritional supplementation: a user's guide | |
Paul et al. | Iron deficiency anemia-An updated overview | |
CN101168051A (zh) | 海洋胶原肽作为制备抗氧化药物、保健食品、食品或化妆品的用途 | |
CN116195739A (zh) | 一种用于肠道清洁的膳食 | |
WO2004084919A1 (ja) | 血中低分子量含窒素化合物の濃度を低減させる病態改善用食品 | |
SPERRY et al. | Essential xanthomatosis: Treatment with cholesterol-free diet in two cases | |
Brophy et al. | Clinical drug therapy for Canadian practice | |
CN117297082B (zh) | 一种检查用代餐组合物及其制备方法 | |
CN110250525A (zh) | 一种用于肠镜检查前清肠的组合物组成及其制备方法 | |
Wall et al. | The Clinician’s Toolkit for the Adult Short Bowel Patient Part I: Nutrition and Hydration Therapy | |
CN102599398B (zh) | 一种补肾清肺果蔬营养粥 | |
Fenwick | Dyspepsia, its varieties and treatment | |
Petersen et al. | Surgery in the gastrointestinal tract | |
Goral et al. | Nutritional management of short bowel syndrome in adult patients | |
CN106036885B (zh) | 重症及术后经鼻肠管行的肠内营养剂及其制备方法 | |
Patil et al. | Intestinal Failure | |
Ali | Comparison between breastfeeding and artificial feeding among infants with acute gastroenteritis in Al-Azizyia General Hospital |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |